Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 7;10:3325–3331. doi: 10.2147/CMAR.S171223

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Ji et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

MRI changes in KHE with decreased knee ROM before and at 12 and 24 months after treatment.

Notes: A 1-year-old boy had pathologically confirmed KHE involving the right ankle. The boy demonstrated progressively decreasing knee ROM for 6 months despite treatment with oral propranolol. MRI revealed the superficial lesion infiltrating the subcutaneous tissue and deep fascia (left). The patient received 12.0 months of sirolimus monotherapy (middle). MRI revealed a partial involution of the lesion. At 3-years of age, MRI showed obvious tumor shrinkage (right).

Abbreviations: KHE, kaposiform hemangioendothelioma; MRI, magnetic resonance imaging; ROM, range of motion.